Phase 3 Trial Examining ICIs in Epithelial Ovarian Cancers Halted Due to Futility
March 31, 2020 11:00 amBy Susan Moench, PhD, PA-C
An interim analysis of results of the first phase 3 clinical trial evaluating an immune checkpoint inhibitor either in combination with or following platinum-based chemotherapy compared with chemotherapy alone in patients with previously untreated advanced … Read more